Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.
Sign Up to like & getrecommendations! Published in 2020 at "Advances in experimental medicine and biology"
DOI: 10.1007/5584_2020_604
Abstract: Two-third of patients with chronic hepatitis C show extrahepatic manifestations due to HCV infection of B lymphocytes, such as mixed cryoglobulinemia and non-Hodgkin B-cell lymphoma, or develop a chronic inflammatory status that may favor the… read more here.
Keywords: daa based; hcv; impact daa; hcv eradication ... See more keywords
The Use of Sofosbuvir (SOF)-containing Direct Antiviral Agents (DAA)-based Regimens Requires Increase in Tacrolimus (Tac) Doses in Kidney Transplant (KT) Recipients with Hepatitis C Virus (HCV) Infection
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation"
DOI: 10.1097/01.tp.0000542896.88696.9a
Abstract: Background In contrast to DAA combinations that include NS3-4A protease inhibitors, the use of SOF-containing regimens based on NS5A inhibitors has not been shown to modify Tac levels after liver transplantation. Specific data on KT… read more here.
Keywords: sof containing; daa based; tac; use ... See more keywords
Spontaneous remission of hepatitis B virus reactivation during direct‐acting antiviral agent‐based therapy for chronic hepatitis C
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology Research"
DOI: 10.1111/hepr.12905
Abstract: The administration of direct‐acting antiviral agents (DAAs) to treat hepatitis C virus (HCV) infection has been reported to cause hepatitis B virus (HBV) reactivation. However, the actual conditions of HBV reactivation and the ideal timing… read more here.
Keywords: daa based; hepatitis; hbv; reactivation ... See more keywords